ARCHIVES

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

ASCO Honors Community Practices For Trial Participation.

June 1, 2007

Elderly and Younger Patients Have Similar Outcomes Following Radioembolization

July 26, 2013

NCAB To Monitor Virus Program; NCI Answers Zinder Report Criticisms

June 28, 1974

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

In Brief: Heavy Smokers More Resistant To Quitting,

March 10, 1995